Association of Vascular Access (AVA): Extravasations Associated with Negative Outcomes
Many adverse outcomes related to vascular access are immediately recognized while others, like extravasation of radiopharmaceuticals, may go unrecognized for a prolonged period of time (sometimes years) and may be associated with negative outcomes including missed diagnosis or suboptimal treatment of nuclear therapy used to treat malignancies. Read more.
Organization of Agreement States (OAS) Request Rulemaking for Extravasations
The Board requests that the NRC accept the petition for rulemaking on extravasations. Until the rule can be finalized, the NMP will need to raise awareness, engage with stakeholders, and develop interim guidance. The Board is confident that through the rulemaking process we will arrive at the best solution for future regulation, and ensure that patients get the highest quality care. Read more.
Experts & Physicians Request Removing Extravasations Reporting Exemption
Many public comments ignored the published scientific papers that describe the ways intravenous access and administration techniques can lead to extravasations, how the extravasated radiopharmaceuticals disperse and clear over time, how localized ionizing radiation injures tissue, and how latent radiation injury effects can take months or years to appear. Read more.
Nuclear Medicine Tech Says Medical Societies are on the Wrong Side of Extravasation Issue
We know significant extravasations can and do happen, are not characterized, and patients are not followed. When centers are aware of a significant extravasation, there are no established mitigation techniques and there are no clear criteria on whether to repeat these studies. However, what is clear to us is that the society is on the wrong side of this issue. Read more.